Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
EP08.03 - Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
-
+
EP08.03-006 - Survival After Radical Treatment of Oligometastatic Non-small Cell Lung Cancer: A Multicenter Analysis
Presenter: Isabelle Opitz- Abstract
Loading...
-
+
P1.14 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Preclinical
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Preclinical
-
+
P1.14-01 - Transcriptomic Analysis of Malignant Pleural Mesothelioma (MPM) Reveals Insights for Basic Research and Preclinical Testing
Presenter: Alexander Laure- Abstract
Loading...
-
+
MA10 - Updates in Thymoma
- 14:45 - 15:45
- 8/08/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
- Moderators:Noboru Yamamoto, Paul J Van Houtte
-
+
MA10.10 - Discussant
15:27 - 15:37 | Presenter: Alessandra Curioni-Fontecedro
- Abstract
Loading...
-
+
OA12 - Novel and Combination Strategies for SCLC
- 16:00 - 17:00
- 8/08/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Moderators:Alessandra Curioni-Fontecedro, Kostas Syrigos
-
+
Session Moderator
16:52 - 17:00 | Presenter: Alessandra Curioni-Fontecedro
- Abstract
Loading... -
+
Session Moderator
16:52 - 17:00 | Presenter: Kostas Syrigos
- Abstract
Loading... -
+
OA12.01 - Session Introduction
16:00 - 16:01 | Presenter: Alessandra Curioni-Fontecedro
- Abstract
Loading... -
+
OA12.02 - Session Introduction
16:01 - 16:02 | Presenter: Kostas Syrigos
- Abstract
Loading... -
+
OA12.03 - Phase 2 Study Analysis of Talazoparib (TALA) Plus Temozolomide (TMZ) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
16:02 - 16:12 | Presenter: Jonathan Goldman
- Abstract
Loading... -
+
OA12.04 - Efficacy of Nivolumab and Temozolomide in Extensive Stage Small Cell Lung Cancer after Chemo-Immunotherapy: A Phase 2 Trial.
16:12 - 16:22 | Presenter: Dwight H Owen
- Abstract
Loading... -
+
OA12.05 - Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer
16:22 - 16:32 | Presenter: Hossein Borghaei
- Abstract
Loading... -
+
OA12.06 - First-Line Pembrolizumab or Placebo Combined With Etoposide and Platinum for ES-SCLC: KEYNOTE-604 Long-Term Follow-Up Results
16:32 - 16:42 | Presenter: Charles M Rudin
- Abstract
Loading... -
+
OA12.07 - Discussant
16:42 - 16:52 | Presenter: Virginie Westeel
- Abstract
Loading... -
+
OA12.08 - Live Q&A
16:52 - 17:00
- Abstract
Loading...
